MarketInOut Stock Screener Log In | Sign Up
 

Eli Lilly & Co

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 05/13/2026 16:00
Eli Lilly & Co stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization845,772 mln
Float889 mln
Earnings Date08/04/2026

EPS

28.17
Exceptional

P / E

36.06
Overvalued

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-1.67
Likely manipulated

1-Year Forecast

1,209
Attractive

Relative Strength

96 / 100
Top performer

Business Description

Founded in 1876 and based in Indianapolis, Indiana, Eli Lilly and Company is a global pharmaceutical company that researches, produces, and sells medicines across the United States, Europe, Asia, and beyond. Its product portfolio spans several major health areas, including diabetes and weight management, cancer treatment, immune system disorders, and neurological conditions such as migraines and Alzheimer's disease. The company also works alongside partners like Boehringer Ingelheim, Roche, and Genentech to bring additional treatments to market.

Key Fundamentals

EPS28.17
P/E36.06
ROE109
RPS80.45
ROIC36.48
ROA23.65
Interest Cover42.47
EBITDA, mln37,817
EV / EBITDA23.80
EV / EBIT25.16
Revenue, mln72,250
EV / Revenue12.46

Financial Strength

Altman Z-Score8.12
Piotroski F-Score 8 / 9
Beneish M-Score-1.67
Price to Lynch Fair Value1.29
Price to Graham Number8.29
1-Year Target Price1,209
Shiller PE Ratio103
Short Ratio2.70
Short % of Float0.91

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.91% 89 / 100   
1 Month 10.11% 89 / 100   
2 Months -8.1% 18 / 100   
6 Months 5.41% 48 / 100   
1 Year 35.43% 77 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us